Journal Article

Addition of Trimethoprim-Sulfamethoxazole to Ceftazidime during Parenteral Treatment of Melioidosis Is Not Associated with a Long-Term Outcome Benefit

Wirongrong Chierakul, Siriluck Anunnatsiri, Wipada Chaowagul, Sharon J. Peacock, Ploenchan Chetchotisakd and Nicholas P. Day

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 45, issue 4, pages 521-523
Published in print August 2007 | ISSN: 1058-4838
Published online August 2007 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/520010
Addition of Trimethoprim-Sulfamethoxazole to Ceftazidime during Parenteral Treatment of Melioidosis Is Not Associated with a Long-Term Outcome Benefit

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Journal Article.  728 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.